The Federal Trade Commission has challenged the validity of over 100 drug product patents, focusing on devices used to deliver medicines, like inhalers and autoinjectors, in an effort to increase competition and potentially lower some prices. The FTC says drugmakers illegitimately use the patents to prevent competitors from offering cheaper generic alternatives. It’s the first time the FTC has tried the tactic, said Hannah Garden-Monheit, director of the FTC’s Office of Policy Planning. “We are using all the tools we have to bring down drug prices and reduce barriers to generic competition,” she said in an interview. President Joe Biden has instructed his Federal Trade
Hence then, the article about the ftc is attacking drugmakers patent thickets was published today ( ) and is available onKHN ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The FTC Is Attacking Drugmakers’ ‘Patent Thickets’ )